Health system implications of direct-to-consumer personal genome testing.
Direct-to-consumer personal genome testing is now widely available to consumers. Proponents argue that knowledge is power but critics worry about consumer safety and potential harms resulting from misinterpretation of test information. In this article, we consider the health system implications of direct-to-consumer personal genome testing, focusing on issues of accountability, both corporate and professional.
Center for Medical Ethics and Health Policy, Baylor College of Medicine, Houston, TX 77030, USA. amcguire@bcm.edu
Amy L
AL
McGuire
Wylie
W
Burke
D054626:Consumer Health Information; D004247:DNA / Q000235:genetics*; D005820:Genetic Testing / Q000941:ethics* / Q000331:legislation & jurisprudence*; D015894:Genome, Human / Q000235:genetics*; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D008389:Marketing of Health Services / Q000941:ethics* / Q000331:legislation & jurisprudence
D004247:DNA